Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment

Retina

Volumn 32, Issue 4, 2012, Pages 799-804

  Shields, Carol L ^a   Kaliki, Swathi ^a   Shah, Sanket U ^a   Bianciotto, Carlos G ^a   Jabbour, Pascal ^b   Shields, Jerry A ^a  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

chemotherapy; eye; intraarterial chemotherapy; retinal detachment; retinoblastoma; tumor

Indexed keywords

CARBOPLATIN; MELPHALAN;

ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE COURSE; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EYE; FEMALE; FOLLOW UP; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MULTIPLE CYCLE TREATMENT; OPHTHALMIC ARTERY; OUTCOME ASSESSMENT; RETINA DETACHMENT; RETINOBLASTOMA; RETROSPECTIVE STUDY; SALVAGE THERAPY; SUBRETINAL FLUID; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INJECTIONS, INTRA-ARTERIAL; MALE; RETINAL DETACHMENT; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 84859110282     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31823d8e1e     Document Type: Article

References (18)

1. Shields CL, Shields JA. Retinoblastoma management: advances inenucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 2010;21:203-212.
2. Abramson DH. Retinoblastoma inthe 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005;46:2684-2691. (Pubitemid 43086687)
3. Shields JA, Shields CL. Intraocular Tumors. An Atlas and Textbook. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:33-52.
4. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-2280. (Pubitemid 44838917)
5. Shields CL, Materin MA, Shields JA. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment. Arch Ophthalmol 2005;123:1610-1613.
6. Shields CL, Shields JA, De Potter P, et al. The effect of chemoreduction on retinoblastoma-induced retinal detachment. J Pediatr Ophthalmol Strabism 1997;34:165-169. (Pubitemid 27220510)
7. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004;9:69-73. (Pubitemid 38619319)
8. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-1404.
9. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina 2009;29:1207-1209.
10. Shields CL, Shields JA. Intra-arterial chemoreduction for retinoblastoma: the beginning of a long journey. Clin Exp Ophthalmol 2010;38:638-643.
11. Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010;117:1623-1629.
12. Shields CL, Bianciotto CG, Ramasubramanian A, et al. Intraarterial chemotherapy for retinoblastoma. Report #1: Control of tumor, subretinal seeds, and vitreous seeds. Arch Ophthalmol 2011, June 13 [E pub ahead of print].
13. Shields CL, Bianciotto CG, Ramasubramanian A, et al. Intraarterial chemotherapy for retinoblastoma. Report #2: treatment complications. Arch Ophthalmol 2011, June 13 [E pub ahead of print].
14. Shields CL, Sun H, Manquez ME, et al. Resolution of iris neovascularization following chemoreduction for advanced retinoblastoma. Arch Ophthalmol 2006;124:1196-1197. (Pubitemid 44232353)
15. Demirci H, Shields CL, Meadows AT, Shields JA. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol 2005;123:1525-1530. (Pubitemid 41626688)
16. Brodie SE, Pierre Gobin Y, Dunkel IJ, et al. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol 2009;119: 13-22.
17. Wilson MW, Qaddoumi I, Billups C, Haik BG, Rodriguez- Galindo C.A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol 2011;95:553-558.
18. Kaliki S, Shields CL, Shah SU, et al. Post-enucleation adjuvant chemotherapy with vincristine, etoposide and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol 2011. In press.